1. Home
  2. MRNA vs CTAS Comparison

MRNA vs CTAS Comparison

Compare MRNA & CTAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moderna Inc.

MRNA

Moderna Inc.

N/A

Current Price

$199.18

Market Cap

91.2B

Sector

Health Care

ML Signal

N/A

Logo Cintas Corporation

CTAS

Cintas Corporation

N/A

Current Price

$218.86

Market Cap

88.8B

ML Signal

N/A

Company Overview

Basic Information
Metric
MRNA
CTAS
Founded
2010
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
91.2B
88.8B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
MRNA
CTAS
Price
$199.18
$218.86
Analyst Decision
Hold
Buy
Analyst Count
23
20
Target Price
$164.53
★ $218.44
AVG Volume (30 Days)
★ 11.4M
1.7M
Earning Date
11-06-2026
12-17-2026
Dividend Yield
N/A
★ 0.94%
EPS Growth
★ 21.77
11.59
EPS
N/A
★ 1.36
Revenue
★ $19,263,000,000.00
$6,892,303,000.00
Revenue This Year
$24.09
$8.71
Revenue Next Year
$11.33
$7.53
P/E Ratio
★ N/A
$163.51
Revenue Growth
★ 4.29
N/A
52 Week Low
$22.28
$161.16
52 Week High
$280.80
$233.46

Technical Indicators

Market Signals
Indicator
MRNA
CTAS
Relative Strength Index (RSI) 43.06 49.68
Support Level $181.02 $193.82
Resistance Level $254.48 $226.69
Average True Range (ATR) 17.92 4.86
MACD -7.14 -1.29
Stochastic Oscillator 11.39 14.93

Price Performance

Historical Comparison
MRNA
CTAS

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About CTAS Cintas Corporation

Cintas has roots dating back to 1929, when the Farmer family cleaned and resold dirty rags to manufacturing plants in Ohio. The firm has expanded its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. At the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid supplies, fire extinguishers, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.

Share on Social Networks: